172 related articles for article (PubMed ID: 15732025)
1. The effect of gender on outcome in digitalis-treated heart failure patients.
Domanski M; Fleg J; Bristow M; Knox S
J Card Fail; 2005 Mar; 11(2):83-6. PubMed ID: 15732025
[TBL] [Abstract][Full Text] [Related]
2. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction.
Dries DL; Exner DV; Gersh BJ; Domanski MJ; Waclawiw MA; Stevenson LW
J Am Coll Cardiol; 1998 Sep; 32(3):695-703. PubMed ID: 9741514
[TBL] [Abstract][Full Text] [Related]
3. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.
Böhm M; Pogue J; Kindermann I; Pöss J; Koon T; Yusuf S
Eur J Heart Fail; 2014 Mar; 16(3):325-33. PubMed ID: 24464788
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.
Benedict CR; Shelton B; Johnstone DE; Francis G; Greenberg B; Konstam M; Probstfield JL; Yusuf S
Circulation; 1996 Aug; 94(4):690-7. PubMed ID: 8772689
[TBL] [Abstract][Full Text] [Related]
5. The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
Parker AB; Yusuf S; Naylor CD
Am Heart J; 2002 Dec; 144(6):941-7. PubMed ID: 12486418
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial.
Al-Khadra AS; Salem DN; Rand WM; Udelson JE; Smith JJ; Konstam MA
J Am Coll Cardiol; 1998 Feb; 31(2):419-25. PubMed ID: 9462588
[TBL] [Abstract][Full Text] [Related]
7. Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative.
Coiro S; Girerd N; Rossignol P; Bauersachs J; Pitt B; Fay R; Ambrosio G; Solomon SD; Dickstein K; Zannad F
Clin Res Cardiol; 2017 Sep; 106(9):722-733. PubMed ID: 28455597
[TBL] [Abstract][Full Text] [Related]
8. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators.
Konstam V; Salem D; Pouleur H; Kostis J; Gorkin L; Shumaker S; Mottard I; Woods P; Konstam MA; Yusuf S
Am J Cardiol; 1996 Oct; 78(8):890-5. PubMed ID: 8888661
[TBL] [Abstract][Full Text] [Related]
9. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study.
Jong P; Yusuf S; Rousseau MF; Ahn SA; Bangdiwala SI
Lancet; 2003 May; 361(9372):1843-8. PubMed ID: 12788569
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction.
Exner DV; Dries DL; Waclawiw MA; Shelton B; Domanski MJ
J Am Coll Cardiol; 1999 Mar; 33(4):916-23. PubMed ID: 10091816
[TBL] [Abstract][Full Text] [Related]
11. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
[TBL] [Abstract][Full Text] [Related]
12. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.
Exner DV; Dries DL; Domanski MJ; Cohn JN
N Engl J Med; 2001 May; 344(18):1351-7. PubMed ID: 11333991
[TBL] [Abstract][Full Text] [Related]
13. Congestive heart failure: new therapeutic strategies.
Pitt B
Clin Cardiol; 1992 Sep; 15 Suppl 1():I2-4. PubMed ID: 1395211
[TBL] [Abstract][Full Text] [Related]
14. Lessons from recent randomized controlled trials for the management of congestive heart failure.
Riegger GA
Am J Cardiol; 1993 Jun; 71(17):38E-40E. PubMed ID: 8328366
[TBL] [Abstract][Full Text] [Related]
15. Sex-based differences in the effect of digoxin for the treatment of heart failure.
Rathore SS; Wang Y; Krumholz HM
N Engl J Med; 2002 Oct; 347(18):1403-11. PubMed ID: 12409542
[TBL] [Abstract][Full Text] [Related]
16. Racial differences in the outcome of left ventricular dysfunction.
Dries DL; Exner DV; Gersh BJ; Cooper HA; Carson PE; Domanski MJ
N Engl J Med; 1999 Feb; 340(8):609-16. PubMed ID: 10029645
[TBL] [Abstract][Full Text] [Related]
17. Digitalis for treatment of heart failure in patients in sinus rhythm.
Hood WB; Dans AL; Guyatt GH; Jaeschke R; McMurray JJ
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD002901. PubMed ID: 24771511
[TBL] [Abstract][Full Text] [Related]
18. Digitalis for treatment of congestive heart failure in patients in sinus rhythm.
Hood WB; Dans A; Guyatt GH; Jaeschke R; McMurray JV
Cochrane Database Syst Rev; 2001; (3):CD002901. PubMed ID: 11687032
[TBL] [Abstract][Full Text] [Related]
19. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Ghali JK; Piña IL; Gottlieb SS; Deedwania PC; Wikstrand JC;
Circulation; 2002 Apr; 105(13):1585-91. PubMed ID: 11927527
[TBL] [Abstract][Full Text] [Related]
20. [Cost effectiveness of ACE inhibition in therapy of chronic heart failure in Switzerland: evaluation based on the SOLVD study].
Szucs TD; Goedde M; Berger K; Kiowski W
Schweiz Med Wochenschr; 1997 Jul; 127(29-30):1234-41. PubMed ID: 9333933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
